Last year, I helped a close friend review a Russian surrogacy and IVF cost sheet line by line. The bottom line read 680,000 RMB (roughly $94,000), and she genuinely believed that was the all-in price. Then I flipped to the very last page of the contract appendix. The columns for surrogate re-screening, annual embryo freezing renewals, and the pregnancy complication contingency fund were completely blank. In overseas reproductive journeys, your budget rarely gets blown up by the major medical milestones. Instead, it gets quietly drained by these tiny, unassuming line items. Here is a transparent breakdown of how the numbers actually play out, ordered by the exact financial traps I have navigated myself.
The Quote Said “Surrogate Screening Included”—It Took Three Tries to Find the Catch
In the first proposal the agency handed us, surrogate medical screening was reduced to a single phrase bundled into the general agency service fee. I asked a simple question: how many rounds of screening does that cover? They replied, “One basic round.” What I learned later is that a standard clinic workup for a surrogate in Russia—covering infectious diseases, a six-panel hormone test, pelvic ultrasound, and psychological evaluation—costs the equivalent of 8,000 to 12,000 RMB ($1,100 to $1,650) locally. The real budget killer isn’t the initial test; it is the re-testing. If her hormone levels are slightly off, or the ultrasound shows a thin endometrial lining, she has to wait a cycle and re-test. Every follow-up check adds another 3,000 RMB ($420) or so.
Here is how that plays out in real life: during our first matching phase, two consecutive candidates failed their initial thyroid panels. We didn’t get a green light until the third candidate. Those two extra rounds of screening, combined with the waiting time between menstrual cycles, pushed our entire timeline back by nearly 50 days. When you review an agency quote, never just ask if screening is included. Ask how many rounds are covered, who pays for re-tests, and whether switching candidates after a failed medical check triggers a new matching fee. I now insist that agencies list every screening item and its unit price in the contract appendix. Even if the package price stays the same, you need to know exactly where the boundary lies.
Why I Created a Separate Budget Line Just for CoQ10 Before the IVF Cycle
Most intended parents only start counting surrogacy expenses from the moment of embryo transfer, treating pre-cycle IVF preparation like pocket change. My own painful lesson taught me otherwise. Because my ovarian reserve was borderline average, my reproductive endocrinologist recommended three full months of nutritional intervention before stimulation. Taking 200 to mg of high-grade imported CoQ10 daily costs 600 to 900 RMB ($85 to $125) a month, adding up to over 2,000 RMB ($300) for a three-month course. That sounds like a drop in the bucket compared to agency fees, but it directly impacts your egg retrieval numbers and how many euploid embryos pass PGT screening. Coming up short by just one viable embryo could force you to restart a whole new IVF stimulation cycle—and that means paying another 100,000+ RMB ($14,000+).
My practical rule of thumb: create a dedicated “90-Day Pre-Cycle Prep” line in your spreadsheet for CoQ10, Vitamin D, and active folate. Do not let these get buried under miscellaneous expenses. When buying supplements, check two things: the actual active ingredient per capsule rather than the front-label marketing weight, and whether the brand provides third-party batch testing reports. I have seen people buy cheap, under-dosed bottles, take them for three months with zero improvement in their AMH or follicle count, and essentially throw both money and precious time down the drain. Set aside 3,000 to 5,000 RMB ($420 to $700) specifically for pre-cycle nutrition, and never cut corners mid-prep.
From a 680k Quote to a 790k Final Bill: Where Did the Extra 110k Go?
By the time my friend brought her baby home, her final ledger sat at 790,000 RMB ($109,000). Where did that extra 110,000 RMB ($15,000) go? Roughly 6,000 RMB went to surrogate re-screening; 4, RMB covered an extra year of embryo cryopreservation; 20,000 RMB went toward the surrogate’s maternity nutrition and local transport allowances; and 15,000 RMB covered the surgical fee difference when an attempted vaginal delivery turned into an emergency C-section. The rest was eaten up by ruble-to-dollar exchange rate swings and two last-minute flight changes. None of these charges were scams. Every single one was mentioned in the fine print, yet completely left out of her initial mental budget.
Here is something you can do immediately upon receiving a quote: open a blank spreadsheet and build a “Variable Cost Tracker.” List out surrogate re-testing, annual embryo storage, multifetal reduction fees, C-section surcharges, pregnancy complication treatments, and baby exit paperwork/notarization. Force your agency coordinator to give you a worst-case cap for each line. Once you have the base package price, multiply it by 1.15—that is your real financial safety net. Standard Russian surrogacy quotes leave these variables out by industry convention, so it is up to you to price them in beforehand.
Why One Agency Quotes 520k and Another Quotes 750k for the Exact Same Cycle
When you see massive price gaps between agencies for a single cycle, the difference rarely lies in the IVF lab fees. It comes down to surrogate matching criteria. Candidates who have proven fertility, pass their medical screening on the first try, and live right next to the clinic command significantly higher compensation packages. Conversely, agencies pitching ultra-low 520,000 RMB ($72,000) packages often rely on candidates who need long-distance travel from remote regions or have borderline medical histories. The upfront price looks tempting, but low screening pass rates, travel logistics, and delayed transfers will eventually eat up whatever money you thought you saved.
Ultimately, breaking down a surrogacy and IVF quote isn’t about hunting for the cheapest number on paper. It is about stress-testing your budget against real-world medical variables so you never have to compromise on clinical quality when it matters most.